info@affiniatx.com
43 Foundry Ave, Suite 120 Waltham, MA 02453

We see what’s possible tomorrow for patients by creating it today

Our purpose is to make a lasting positive impact on the lives of those affected by devastating diseases.

Read Our Story

We are drug developers and creators. We are Affinians

We are a team with decades of proven success in translating science from bench to bedside across many companies and medicines. We’re using our deep expertise to set a new standard in gene therapy.

Meet Our Team

We are the next generation of gene therapies

There’s a new frontier in the fight against devastating rare and prevalent diseases, and Affinia Therapeutics is pioneering the way. We’re expanding what’s possible with adeno-associated virus (AAV) gene therapy, starting with diseases of the heart and of the nervous system.

Explore Our Pipeline

We call it ART and its breakthrough science

With our proprietary ART (Affinia Rationally-designed Therapies) platform, we employ AI and structural modeling to rationally design the gene therapies of tomorrow – ones that better target tissues and so, may improve safety and effectiveness.

Explore Our Science

We are writing news every day

The work we do is innovative and newsworthy. It’s covered in leading scientific and industry conferences and journals.

Read Our News

Our Pipeline

Read More

Our Platform

Take a look at what sets Affinians apart
Read More

Learn more about the building blocks of a gene therapy

Read More

We see what’s possible tomorrow by creating it today

There’s a new frontier in the fight against devastating rare and prevalent diseases, and Affinia Therapeutics is leading the way. We’re expanding what’s possible in adeno‑associated virus (AAV) gene therapy today to bring transformative medicines for people in need tomorrow.

Read Our Story
Affinia_Sept-2024_HP_1200x900
home page - 2
home page - 3 (1)

Developing therapies
with breakthrough
rational design science

With our proprietary ART: Affinia Rationally-designed Therapies platform we generate a deep understanding of how structure impacts function to rationally design the gene therapies of tomorrow.

Explore Our Science
LATEST NEWS

Read our latest news

November 13, 2024

Affinia Therapeutics and Forge Biologics Announce AAV cGMP Manufacturing Partnership to Advance Affinia Therapeutics’ Pipeline of Next-Generation Gene Therapies to the Clinic

View More
October 24, 2024

ESGCT 2024: Affinia’s Proprietary AAV Plasmid Design Produces Industry Leading Manufacturability of Novel and WT Capsids

View More
October 24, 2024

ESGCT 2024: In Vitro Binding to Human and NHP Orthologs of Candidate Receptors Identify Novel Systemically Delivered AAVs With Enhanced CNS Tropism

View More
View All News

Contact Info

info@affiniatx.com

Office Address

Affinia Therapeutic
43 Foundry Ave, Suite 120 Waltham, MA 02453
Linkedin-in